When the session moderator asked whether the findings meant cardiovascular risk was no longer a worry with JAK inhibitors ...

USA: A recent post hoc analysis of the ORAL Surveillance trial has highlighted the essential role of statins in mitigating major adverse cardiovascular events (MACE) among patients with rheumatoid ...

A non-significant dose-dependent response trend was observed from 1 to 5 mg bid (Additional file 3: Figure S1). ACR20 response rates were significantly greater in tofacitinib treatment versus ...